Why the study?
Although cardiometabolic disease is more prevalent in men, the relative risk of CVD conferred by cardiometabolic conditions is higher in women, prompting investigation into sex-specific associations with subclinical cardiac remodeling.
Does sex modify the association between cardiometabolic disease burden and subclinical cardiac remodeling?
Does sex modify the association between cardiometabolic disease burden and subclinical cardiac remodeling?
Higher cardiometabolic disease burden is more strongly associated with subclinical left ventricular systolic and diastolic dysfunction in women compared to men.
Answers are grounded in this paper and cite their sources.
May support sex-specific cardiometabolic monitoring in women; hypothesis-generating and requires longitudinal validation.
AIMS: Although the prevalence of cardiometabolic disease is greater in men vs women, the relative risk of cardiovascular disease (CVD) conferred by cardiometabolic conditions is higher in women than in men. We examined the sex-specific association of cardiometabolic risk factor burden with subclinical echocardiographic cardiac remodeling. METHODS: In this cross-sectional study, we examined whether sex modifies the association between cardiometabolic disease burden (measured as metabolic syndrome severity [MetSS] score) with echocardiographic markers of subclinical cardiac remodeling (including global longitudinal strain [GLS] and E/e' ratio) using multiplicative interaction terms in multivariable-adjusted linear regression models. RESULTS: Among 6182 Framingham Heart Study participants (mean age 51 ± 15 years; 54% women), we observed that sex modifies the association between the MetSS score and subclinical markers of left ventricular systolic and diastolic function. Specifically, a higher MetSS score was associated with worse GLS and E/e' ratio in women versus men. For example, every 1-point increase in the MetSS score was associated with 0.35% higher (worse) GLS in women compared with 0.23% higher GLS in men (ß 0.35, SE 0.04 in women versus ß 0.23, SE 0.04 in men, pint 0.01). Similarly, the MetSS score was more strongly associated with a higher (worse) E/e' ratio in women versus men (ß 0.29, SE, 0.02 in women versus ß, 0.20, SE, 0.02 in men, pint <0.001). CONCLUSION: We observed that sex modifies the association of cardiometabolic disease burden with subclinical markers of cardiac dysfunction. Specifically, higher cardiometabolic disease burden was associated with worse GLS and E/e' ratio in women versus men.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: